Petr G. Aparin

Moscow, MOW 115478, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A Candidate Ac3-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized Phase 2 Clinical Trial.

A Candidate Ac3-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized Phase 2 Clinical Trial.

Journal: Vaccines

Published: December 26, 2024

Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study.

Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study.

Journal: Bulletin of experimental biology and medicine

Published: December 23, 2022

A Pentavalent Shigella flexneri LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal Models.

A Pentavalent Shigella flexneri LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal Models.

Journal: Vaccines

Published: December 15, 2022

High-Level Production of Soluble Cross-Reacting Material 197 in Escherichia coli Cytoplasm Due to Fine Tuning of the Target Gene's mRNA Structure.

High-Level Production of Soluble Cross-Reacting Material 197 in Escherichia coli Cytoplasm Due to Fine Tuning of the Target Gene's mRNA Structure.

Journal: Biotech (Basel (Switzerland))

Published: November 18, 2022

Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4.

Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4.

Journal: Vaccines

Published: September 30, 2022

Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Journal: Vaccine

Published: August 08, 2018

Study of cross-activity of Streptococcus pneumoniae antigen preparations

Study of cross-activity of Streptococcus pneumoniae antigen preparations

Journal: Zhurnal mikrobiologii, epidemiologii i immunobiologii

Published: November 21, 2012

Shigella flexneri O-antigens revisited: final elucidation of the O-acetylation profiles and a survey of the O-antigen structure diversity.

Shigella flexneri O-antigens revisited: final elucidation of the O-acetylation profiles and a survey of the O-antigen structure diversity.

Journal: FEMS immunology and medical microbiology

Published: February 28, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026